| BEVS | Baculovirus expression vector system |
| HPV | Human papillomavirus |
| AcMNPV | Autographa californica multicapsid nucleopolyhedrovirus |
| BmNPV | Bombyx mori nucleopolyhedrovirus |
| VLPs | Virus-like particles |
| RNAi | RNA interference |
| BSS | Burst sequences |
| hr1 | Homologous region 1 |
| sgMultiple | Multiple editing anti-BmNPV therapeutic complex CRISPR-Cas9 system, PSL1180-Cas9-sgIE1-sgLEF11-sgGP64 |
| rBV | Recombinant baculovirus |
| RNAi | RNA interference |
| FDL | Fused lobed |
| rHA | Recombinant trivalent hemagglutinin |
| HA | Hemagglutinin |
| RIV4 | Quadrivalent recombinant influenza vaccine |
| IIV4 | Quadrivalent-inactivated influenza vaccines |
| hACE2 | Human angiotensin-converting enzyme 2 |
| S | spike |
| preS dTM | Prefusion transmembrane-deleted spike |
| M1 | Matrix protein 1 |
| EBOV | Ebola virus |
| RSV | Respiratory syncytial virus |
| F | Fusion |
| AAV | Adeno-associated virus |
| ZIKV | Zika virus |
| E | Envelope |
| rWNV-E | Recombinant West Nile virus truncated envelope protein antigen |
| DENV | Dengue virus |